Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for TDNT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
May 31, 2022 -31.95M
February 28, 2022 -31.37M
November 30, 2021 -30.68M
August 31, 2021 -29.72M
May 31, 2021 -29.21M
February 28, 2021 -28.57M
November 30, 2020 -28.03M
August 31, 2020 -55.18M
May 31, 2020 -42.49M
February 29, 2020 -32.46M
November 30, 2019 -24.25M
August 31, 2019 -21.19M
May 31, 2019 -19.08M
February 28, 2019 -15.46M
November 30, 2018 -12.53M
August 31, 2018 -9.492M
May 31, 2018 -7.875M
February 28, 2018 -7.098M
November 30, 2017 -5.849M
August 31, 2017 -3.203M
May 31, 2017 -1.975M
February 28, 2017 -2.420M
November 30, 2016 -1.473M
August 31, 2016 -1.705M
May 31, 2016 -1.119M
Date Value
February 29, 2016 -0.5461M
November 30, 2015 -2.595M
August 31, 2015 -1.828M
May 31, 2015 -1.106M
February 28, 2015 -0.4537M
November 30, 2014 -0.5699M
August 31, 2014 -0.3478M
May 31, 2014 -0.2032M
February 28, 2014 -0.0666M
November 30, 2013 -0.0607M
August 31, 2013 -0.0459M
May 31, 2013 -0.0329M
February 28, 2013 -0.0084M
November 30, 2012 -0.0053M
August 31, 2012 -0.0019M
May 31, 2012 -0.0185M
February 29, 2012 -0.0132M
November 30, 2011 -0.0077M
August 31, 2011 -0.0035M
May 31, 2011 -0.0001M
February 28, 2011 0.0033M
November 30, 2010 0.009M
August 31, 2010 0.0124M
May 31, 2010 0.0157M
February 28, 2010 0.0189M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Herborium Group, Inc. -4.299M
Entia Biosciences, Inc. --
Nunzia Pharmaceutical Corp. --
Cyanotech Corp. 7.985M
Mannatech, Inc. -4.97M